Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AstraZeneca and Isis Pharmaceuticals to Co-Develop Targeted Oligonucleotide Delivery Methods
Yahoo
Thursday, November 13, 2014 - 9:38am
tags:
AstraZeneca, Isis Pharmaceuticals, drug delivery, oligonucleotide
4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic
24/7 Wall St
Thursday, November 13, 2014 - 9:34am
tags:
hepatitis C, AbbVie, Achillion, Gilead Sciences, Merck
The Rationale For Using Brincidofovir (BCV) In Ebola Patients
Forbes
Thursday, November 13, 2014 - 8:22am
tags:
Brincidofovir, ebola virus, Chimerix
AstraZeneca developing reversal agent for heart drug Brilinta
Yahoo/Reuters
Thursday, November 13, 2014 - 8:13am
tags:
AstraZeneca, Brilinta
U.S. gene study raises hope for Merck cholesterol drug Zetia
Yahoo/Reuters
Thursday, November 13, 2014 - 8:11am
tags:
Merck, Zetia
Obesity drug war may be about more than marketing to the overweight
Medical Marketing and Media
Wednesday, November 12, 2014 - 4:52pm
tags:
obesity, Contrave, Orexigen, Eisai
1 Biotech Beast Worth Tracking
Yahoo/Benzinga
Wednesday, November 12, 2014 - 4:37pm
tags:
Incyte, Merck, Novartis, Eli Lilly, Pfizer
Pharma Trade Group Head Causes a Stir With a Remark About Patents
WSJ Pharmalot
Wednesday, November 12, 2014 - 4:32pm
tags:
International Federation of Pharmaceutical Manufacturers Association, patents
Missing the old pharma swag? Take a trip down memory lane
Fierce Pharma Marketing
Wednesday, November 12, 2014 - 1:22pm
tags:
drug reps, pharma industry
Indian drugmakers see U.S. sales hit by delay in new approvals
Reuters
Wednesday, November 12, 2014 - 11:48am
tags:
India, FDA, drug approvals
Takeda's Millennium re-ups with Presage on cancer drug combo effort
Fierce Biotech
Wednesday, November 12, 2014 - 11:46am
tags:
Takeda, Millennium Pharmaceuticals, Presage Biosciences, cancer
Survey: Hospitals clamp down on medical device expenses
Mass Device
Wednesday, November 12, 2014 - 11:43am
tags:
devices
[video] What Makes Allergan an Attractive Target for Actavis?
Bloomberg
Wednesday, November 12, 2014 - 11:43am
tags:
Allergan, Actavis, M&A
Don’t expect a Dendreon sale; the troubled biotech will likely end up as a new entity with the current common shares cancelled
Barron's
Wednesday, November 12, 2014 - 11:02am
tags:
Dendreon, bankruptcy
Actavis Said in Talks to Acquire Allergan for Over $60 Billion
Bloomberg
Wednesday, November 12, 2014 - 10:50am
tags:
Actavis, Allergan, M&A
TEVA: Copaxone Patent Expiry Worries Are Overblown
Seeking Alpha
Wednesday, November 12, 2014 - 8:44am
tags:
Teva Pharmaceutical, Copaxone, MS, multiple sclerosis, patents
Should Johnson & Johnson Buy Medivation Inc.?
Motley Fool
Wednesday, November 12, 2014 - 8:41am
tags:
JNJ, Medivation, M&A, Xtandi, prostate cancer
Could Zoetis (ZTS) Be Ackman’s Next Pitch To Valeant Pharmaceuticals (VRX)?
Bidness Etc.
Wednesday, November 12, 2014 - 8:39am
tags:
Zoetis, Bill Ackman, M&A, Valeant Pharmaceuticals, animal health
Oxigene Faces Challenges for Ovarian Cancer Drug Even With Encouraging Data
TheStreet.com
Wednesday, November 12, 2014 - 8:38am
tags:
Oxigene, ovarian cancer, fosbretabulin, Avastin
Allergan amends shareholder meeting bylaws ahead of Dec. 18 meet
Yahoo/Reuters
Wednesday, November 12, 2014 - 8:35am
tags:
Allergan, Valeant Pharmaceuticals, shareholders, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.